Citation Impact
Citing Papers
Keeping G Proteins at Bay: A Complex Between G Protein-Coupled Receptor Kinase 2 and Gßγ
2003 StandoutScienceNobel
Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
2019 StandoutScienceNobel
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
2002 StandoutScienceNobel
The Dopamine D1D Receptor
1995
Stereoselective synthesis and preliminary evaluation of (+)- and (–)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonist
2004
The Active Conformation of β-Arrestin1
2007 StandoutNobel
G Protein-Coupled Receptor Kinase Function Is Essential for Chemosensation in C. elegans
2004 StandoutNobel
Cloning Genes Encoding Receptors Related to Chemoattractant Receptors
1998
Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice
1999 StandoutNobel
Descending control of pain
2002 Standout
Clathrin-mediated Endocytosis of the β-Adrenergic Receptor Is Regulated by Phosphorylation/Dephosphorylation of β-Arrestin1
1997 StandoutNobel
Prolonged Kappa Opioid Receptor Phosphorylation Mediated by G-protein Receptor Kinase Underlies Sustained Analgesic Tolerance
2004 StandoutNobel
The delta opioid receptor: an evolving target for the treatment of brain disorders
2011
Nociceptive Signals Induce Trafficking of TRPA1 to the Plasma Membrane
2009 StandoutNobel
Roof and Floor of the Muscarinic Binding Pocket: Variations in the Binding Modes of Orthosteric Ligands
2007
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
Direct protein–protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors
2000 Nature
Tolerance to μ‐opioid agonists in human neuroblastoma SH‐SY5Y cells as determined by changes in guanosine‐5′‐O‐(3‐[35S]‐thio)triphosphate binding
1997
Molecular mechanisms of opiate and cocaine addiction
1997
Arrestin/Clathrin Interaction
1997
Hypoxic Induction of the Regulator of G-Protein Signalling 4 Gene Is Mediated by the Hypoxia-Inducible Factor Pathway
2012
Novel dopamine receptors half a decade later
1995
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
2012 StandoutNatureNobel
The Rise and Fall of the Chemoattractant Receptor GPR33
2005 StandoutNobel
Role of delivery and trafficking of δ-opioid peptide receptors in opioid analgesia and tolerance
2006
Trafficking Patterns of β-Arrestin and G Protein-coupled Receptors Determined by the Kinetics of β-Arrestin Deubiquitination
2003 StandoutNobel
β-Arrestin1 Interacts with the Catalytic Domain of the Tyrosine Kinase c-SRC
2000 StandoutNobel
Activation-dependent Conformational Changes in β-Arrestin 2
2004 StandoutNobel
Synapse-Specific, Long-Term Facilitation of Aplysia Sensory to Motor Synapses: A Function for Local Protein Synthesis in Memory Storage
1997 StandoutNobel
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Understanding the Stepwise Synthesis of Glycolipids
2002
Reciprocal Regulation of Angiotensin Receptor-activated Extracellular Signal-regulated Kinases by β-Arrestins 1 and 2
2004 StandoutNobel
Iron catalysed direct alkylation of amines with alcohols
2014 StandoutNobel
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
2012 StandoutNatureNobel
Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets
2002
Dopamine receptors and brain function
1996
Distinct Saturable Pathways for the Endocytosis of Different Tyrosine Motifs
1998 StandoutNobel
Homo- and Hetero-oligomerization of Thyrotropin-releasing Hormone (TRH) Receptor Subtypes
2002 StandoutNobel
Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration
2002 StandoutNobel
Structure of the δ-opioid receptor bound to naltrindole
2012 StandoutNatureNobel
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
β-Arrestins Regulate Protease-activated Receptor-1 Desensitization but Not Internalization or Down-regulation
2002 StandoutNobel
Structure and dynamics of the M3 muscarinic acetylcholine receptor
2012 StandoutNatureNobel
Seven-transmembrane receptors
2002 StandoutNobel
Oligomerization of μ- and δ-Opioid Receptors
2000
Mutagenic Mapping Suggests a Novel Binding Mode for Selective Agonists of M1 Muscarinic Acetylcholine Receptors
2008
Neuropathic Pain Activates the Endogenous κ Opioid System in Mouse Spinal Cord and Induces Opioid Receptor Tolerance
2004 StandoutNobel
Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway
1999 StandoutNobel
THE ROLE OF RECEPTOR KINASES AND ARRESTINS IN G PROTEIN–COUPLED RECEPTOR REGULATION
1998
β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking
2001 StandoutNobel
Regional, developmental, and cell cycle-dependent differences in ?, ?, and ?-opioid receptor expression among cultured mouse astrocytes
1998
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
2004 StandoutNobel
The assembly and secretion of ApoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins.
1992
Differential expression of receptors for Shiga and Cholera toxin is regulated by the cell cycle
2002
Memory Suppressor Genes: Inhibitory Constraints on the Storage of Long-Term Memory
1998 StandoutScienceNobel
Fast structural responses of gap junction membrane domains to AB5 toxins
2013 StandoutNobel
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
2000 StandoutNatureNobel
Recent Developments in Isocyanide Based Multicomponent Reactions in Applied Chemistry
2005 Standout
Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity
2000 StandoutNobel
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Ganglioside metabolism. Enzymology, Topology, and regulation.
1993
Drug Abuse: Hedonic Homeostatic Dysregulation
1997 StandoutScience
Control of Memory Formation Through Regulated Expression of a CaMKII Transgene
1996 StandoutScienceNobel
Differential Mechanisms of Morphine Antinociceptive Tolerance Revealed in βArrestin-2 Knock-Out Mice
2002 StandoutNobel
Computational Modeling Approaches to Structure−Function Analysis of G Protein-Coupled Receptors
2005
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
1996 StandoutNobel
Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling
2005 StandoutNobel
Neuroscience: Breaking Down Scientific Barriers to the Study of Brain and Mind
2000 StandoutScienceNobel
Molecular Mechanisms and Regulation of Opioid Receptor Signaling
2000
Update 1 of: Computational Modeling Approaches to Structure–Function Analysis of G Protein-Coupled Receptors
2011
Molecular and Cellular Basis of Addiction
1997 Science
Dopamine Receptors: From Structure to Function
1998 Standout
Transduction of Receptor Signals by ß-Arrestins
2005 StandoutScienceNobel
Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference
2003 StandoutNobel
Works of Mark A. Scheideler being referenced
Up-Regulation of Regulator of G Protein Signaling 4 Expression in a Model of Neuropathic Pain and Insensitivity to Morphine
2003
Recent Advances in the Development of Dopamine D3 Receptor Agonists and Antagonists
2001
The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death
2002
The Cloning and Chromosomal Mapping of Two Novel Human Opioid-Somatostatin-like Receptor Genes, GPR7 and GPR8, Expressed in Discrete Areas of the Brain
1995
Characteristics of stably expressed human dopamine D1a and D1b receptors: Atypical behavior of the dopamine D1b receptor
1994
Evidence for a Selective Role of the δ-Opioid Agonist [8 R-(4b S*,8aα,8aβ,12bβ)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9 H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline Hydrochloride (SB-235863) in Blocking Hyperalgesia Associated with Inflammatory and Neuropathic Pain Responses
2003
Dopamine D1B Receptor Chimeras Reveal Modulation of Partial Agonist Activity by Carboxyl‐Terminal Tail Sequences
1998
Cell‐Cycle Dependence of a Ganglioside Glycosyltransferase Activity and Its Inhibition by Enkephalin in a Neurotumor Cell Line
1984
[5] Glycerophosphate acyltransferase from Escherichia coli
1992
Stepwise Modulation of Neurokinin-3 and Neurokinin-2 Receptor Affinity and Selectivity in Quinoline Tachykinin Receptor Antagonists
2001
Cell Cycle‐Dependent Expression of Specific Opiate Binding with Variable Coupling to Adenylate Cyclase in a Neurotumor Hybrid Cell Line NG108–15
1983
Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
1996
Direct Demonstration of the Activation of UDP‐N‐Acetylgalactosamine: [GM3]N‐Acetylgalactosaminyltransferase by Cyclic AMP
1986